BioPharma

Thermo Fisher Scientific has taken a significant step toward achieving its sustainability goals by signing a 10-year virtual power purchase agreement (VPPA) with renewable energy developer X-ELIO. This agreement supports the Lorca solar project, which is set to become...

With a growing shift towards tailored therapies for cancer treatment, personalized medicine emerges as a groundbreaking solution. Cancer has been a major cause of concern among healthcare professionals and patients at the global level. As per the report of...

In the rapidly advancing landscape of healthcare, 4D Lifetec emerges as a trailblazer, aiming to redefine the paradigm of early cancer detection. At the forefront of this innovative journey is the Lifetest™, a user-friendly and proprietary immunological liquid biopsy...

The scenario is that the regulators are all ramping up pressure when it comes to the biopharma industry in 2024. Pharma companies not only happen to need to jump through new hoops when it comes to an increasingly intricate...

It is worth noting that the biopharmaceutical sector has gone on to experience a revival when it comes to mergers and acquisitions in the second half of 2023. One can see three major reasons resulting in this uptick in...

In the last five years, there have been various local governments in the Asia-Pacific region that have enacted beneficial policies and also regulatory frameworks to push healthcare and expedite drug development in their respective markets. These initiatives have contributed...

Biotech companies go on to face numerous challenges, particularly while in the clinical phase of drug development, in today's fast-paced industry. The astronomically high costs, complicated manufacturing processes, as well as regulatory hurdles related to biologics can go on...